Pathophysiological processes following subarachnoid hemorrhage (SAH) present survivors
of the initial bleeding with a high risk of morbidity and mortality during the course of the …

Abstract Purpose of Review Aneurysmal subarachnoid hemorrhage remains a devastating
disease process despite medical advances made over the past 3 decades. Much of the …

Delayed cerebral vasospasm has classically been considered the most important and
treatable cause of mortality and morbidity in patients with aneurysmal subarachnoid …

✓ In an effort to help clarify the current state of medical therapy for cerebral vasospasm, the
authors reviewed the relevant literature on the established medical therapies used for …

Abstract CEREBRAL VASOSPASM REMAINS a devastating medical complication of
aneurysmal subarachnoid hemorrhage (SAH). It is associated with high morbidity and …

Cerebral vasospasm is the classic cause of delayed neurological deterioration leading to
cerebral ischemia and infarction, and thus, poor outcome and occasionally death, after …

Despite an undisputed association between vasospasm and delayed cerebral ischemia
after aneurysmal subarachnoid hemorrhage (SAH), there is debate if this association implies …

Aneurysmal subarachnoid hemorrhage (SAH) remains a serious cerebrovascular disease.
Even if SAH patients survive the initial insults, delayed cerebral ischemia (DCI) may occur at …

Background and purpose: Despite a significant reduction of angiographic vasospasm, the
reduction of poor functional outcome in clinical trials on aneurysmal subarachnoid …

As it is often assumed that delayed cerebral ischemia (DCI) after subarachnoid hemorrhage
(SAH) is caused by vasospasm, clinical trials often focus on prevention of vasospasm with …